Pacira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Pacira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Pacira Pharma (PCRX) Tops Q4 EPS by 28c

February 28, 2018 8:11 AM EST

Pacira Pharma (NASDAQ: PCRX) reported Q4 EPS of $0.38, $0.28 better than the analyst estimate of $0.10. Revenue for the quarter came in at $79.1 million versus the consensus estimate of $79.32 million.

2018 Outlook

Pacira announces its full year 2018 financial guidance as follows. Pacira expects:

EXPAREL net... More